AVX-70371

N/A

Report date: 2025/06/09 20:00:12

Base Information

Drug NameAVX-70371

Drug Alias NameYFV-HBc PLLAVAVX70371AVX-70371

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Live attenuated vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis B, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAstriVax Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesAstriVax Therapeutics

Inactive CompaniesN/A

Active IndicationsHepatitis B, Chronic

Inactive IndicationsN/A

Other Information

ATC CodeN/A